Chemical proteomic analysis reveals the drugability of the kinome of Trypanosoma brucei.

ACS Chem Biol 2012 Nov 23;7(11):1858-65. Epub 2012 Aug 23.

Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, U.K.

The protozoan parasite Trypanosoma brucei is the causative agent of African sleeping sickness, and there is an urgent unmet need for improved treatments. Parasite protein kinases are attractive drug targets, provided that the host and parasite kinomes are sufficiently divergent to allow specific inhibition to be achieved. Current drug discovery efforts are hampered by the fact that comprehensive assay panels for parasite targets have not yet been developed. Here, we employ a kinase-focused chemoproteomics strategy that enables the simultaneous profiling of kinase inhibitor potencies against more than 50 endogenously expressed T. brucei kinases in parasite cell extracts. The data reveal that T. brucei kinases are sensitive to typical kinase inhibitors with nanomolar potency and demonstrate the potential for the development of species-specific inhibitors.

Download full-text PDF

Source
http://dx.doi.org/10.1021/cb300326zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621575PMC
November 2012
7 Reads

Publication Analysis

Top Keywords

trypanosoma brucei
8
brucei kinases
8
parasite
5
data reveal
4
divergent allow
4
allow specific
4
chemoproteomics strategy
4
inhibitor potencies
4
inhibition achieved
4
extracts data
4
specific inhibition
4
reveal brucei
4
kinomes divergent
4
targets provided
4
sensitive typical
4
drug targets
4
attractive drug
4
profiling kinase
4
provided host
4
parasite kinomes
4

Altmetric Statistics

Similar Publications